Table 1.
Characteristics of patients at the initial transurethral resection.
| Clinical characteristics | Non-referred group | Referred group | P value |
|---|---|---|---|
| Number of patients | 220 | 69 | |
|
| |||
| Sex | 0.998 | ||
|
| |||
| Male | 186 (84.5%) | 59 (85.5%) | |
|
| |||
| Female | 34 (15.5%) | 10 (14.5%) | |
|
| |||
| BMI | 23.9±2.9 | 24.0±3.0 | 0.878 |
|
| |||
| Gross hematuria | 173 (79.0%) | 53 (76.8%) | 0.828 |
|
| |||
| Number of previous TURBT | <0.001 | ||
|
| |||
| 0 | 203 (92.3%) | 9 (13.0%) | |
|
| |||
| 1 | 9 (4.1%) | 52 (75.4%) | |
|
| |||
| ≥2 | 8 (3.6%) | 8 (11.6%) | |
|
| |||
| Previous intravesical therapy | 6 (2.7%) | 9 (13.0%) | 0.002 |
|
| |||
| T stage | 0.260 | ||
|
| |||
| Ta | 33 (15.0%) | 15 (21.7%) | |
|
| |||
| T1 | 187 (85.0%) | 54 (78.3%) | |
|
| |||
| Tumor grade | 0.779 | ||
|
| |||
| Low | 32 (14.5%) | 21 (30.4%) | |
|
| |||
| High | 188 (85.5%) | 48 (69.6%) | |
|
| |||
| Tumor multiplicity | <0.001 | ||
|
| |||
| 1 | 107 (48.7%) | 34 (49.3%) | |
|
| |||
| 2-7 | 89 (40.4%) | 30 (43.5%) | |
|
| |||
| >8 | 24 (10.9%) | 5 (7.2%) | |
|
| |||
| Tumor size | <0.001 | ||
|
| |||
| < 3cm | 152 (69.1%) | 55 (79.7%) | |
|
| |||
| ≥ 3cm | 68 (30.9%) | 14 (20.3%) | |
|
| |||
| Concomitant CIS | 20 (9.0%) | 4 (5.8%) | 0.006 |
|
| |||
| LVI | 9 (4.1%) | 0 (0.0%) | 0.190 |
BMI: body mass index; TURBT: transurethral resection of bladder tumor; CIS: carcinoma in situ; LVI: lymphovascular invasion.